|
Volumn 313, Issue 16, 2015, Pages 1613-1614
|
Induced pluripotent stem cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TRANSCRIPTION FACTOR;
CELL DIFFERENTIATION;
CELL THERAPY;
CHROMOSOME REARRANGEMENT;
CRISPR CAS SYSTEM;
DRUG SCREENING;
ECTODERM;
EMBRYONIC STEM CELL;
ENDODERM;
EPIGENETICS;
GENETIC DISORDER;
GENETIC VARIABILITY;
GENOME;
HIGH THROUGHPUT SCREENING;
HUMAN;
IMMUNOGENICITY;
MESODERM;
NONHUMAN;
NUCLEAR REPROGRAMMING;
PHENOTYPE;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
SHORT SURVEY;
SOMATIC MUTATION;
TISSUE REGENERATION;
DRUG DESIGN;
PERSONALIZED MEDICINE;
STEM CELL TRANSPLANTATION;
TRENDS;
DRUG DESIGN;
GENOME;
HUMANS;
INDIVIDUALIZED MEDICINE;
INDUCED PLURIPOTENT STEM CELLS;
PHENOTYPE;
STEM CELL TRANSPLANTATION;
|
EID: 84928727557
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.1846 Document Type: Short Survey |
Times cited : (44)
|
References (8)
|